autologous tumor infiltrating lymphocytes LN-145-S1
Term · Oncology and biomedicine · MLC-T-ONC-011796
A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential immunomodulating and antineoplastic activities. The autologous TILs are isolated from an autologous tumor sample and expanded ex vivo in the presence of interleukin-2 (IL-2). Upon infusion of the autologous TILs LN-145-S1 back into the patient, the cells specifically recognize, target and kill the patient's tumor cells.
| Identifier | MLC-T-ONC-011796 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous TILs LN-145-S1; LN145-S1; autologous tumor-infiltrating lymphocytes LN-145-S1 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011796",
"term": "autologous tumor infiltrating lymphocytes LN-145-S1",
"field": "Oncology and biomedicine",
"definition": "A proprietary preparation of autologous tumor infiltrating lymphocytes (TILs), with potential immunomodulating and antineoplastic activities. The autologous TILs are isolated from an autologous tumor sample and expanded ex vivo in the presence of interleukin-2 (IL-2). Upon infusion of the autologous TILs LN-145-S1 back into the patient, the cells specifically recognize, target and kill the patient's tumor cells.",
"synonyms": [
"autologous TILs LN-145-S1",
"LN145-S1",
"autologous tumor-infiltrating lymphocytes LN-145-S1"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-tumor-infiltrating-lymphocytes-ln-145-s1/"
}
Record 3,134 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.